Explore

TrendlineTrendline
Wolverine Worldwide Reports Strong Q3 2026 Earnings, Driven by Active Brands and DTC Growth

Wolverine Worldwide Reports Strong Q3 2026 Earnings, Driven by Active Brands and DTC Growth

Wolverine Worldwide Reports Strong Q3 2026 Earnings, Driven by Active Brands and DTC Growth
TrendlineTrendline
Medline Stock Falls as Investors Scrutinize Profit Quality and Future Margin Risks

Medline Stock Falls as Investors Scrutinize Profit Quality and Future Margin Risks

Medline Stock Falls as Investors Scrutinize Profit Quality and Future Margin Risks
TrendlineTrendline
Wolverine World Wide Exceeds Q3 Expectations, Raises Full-Year Outlook Amidst Strong Brand Performance

Wolverine World Wide Exceeds Q3 Expectations, Raises Full-Year Outlook Amidst Strong Brand Performance

Wolverine World Wide Exceeds Q3 Expectations, Raises Full-Year Outlook Amidst Strong Brand Performance
TrendlineTrendline
FGI Industries Reports Q3 2026 Revenue Decline Amidst Challenging Market

FGI Industries Reports Q3 2026 Revenue Decline Amidst Challenging Market

FGI Industries Reports Q3 2026 Revenue Decline Amidst Challenging Market
TrendlineTrendline
Alvotech Reports Decreased Total Revenue for Nine Months Ending September 2026, Maintains Full-Year Guidance

Alvotech Reports Decreased Total Revenue for Nine Months Ending September 2026, Maintains Full-Year Guidance

Alvotech Reports Decreased Total Revenue for Nine Months Ending September 2026, Maintains Full-Year Guidance
TrendlineTrendline
Hansa Biopharma Reports Significant Revenue Increase in Q3 2026 Driven by Licensing Agreement

Hansa Biopharma Reports Significant Revenue Increase in Q3 2026 Driven by Licensing Agreement

Hansa Biopharma Reports Significant Revenue Increase in Q3 2026 Driven by Licensing Agreement
TrendlineTrendline
SeaStar Medical Reports Strong Q3 2026 Revenue Growth, Updates NEUTRALIZE-AKI Trial Timeline

SeaStar Medical Reports Strong Q3 2026 Revenue Growth, Updates NEUTRALIZE-AKI Trial Timeline

SeaStar Medical Reports Strong Q3 2026 Revenue Growth, Updates NEUTRALIZE-AKI Trial Timeline
TrendlineTrendline
Atlanta Braves Holdings Reports Q3 Revenue Increase Amidst Nine-Month Net Loss

Atlanta Braves Holdings Reports Q3 Revenue Increase Amidst Nine-Month Net Loss

Atlanta Braves Holdings Reports Q3 Revenue Increase Amidst Nine-Month Net Loss
TrendlineTrendline
Immunome Reports Strong Q3 2026 Financial Results and Advances Oncology Pipeline with New Clinical Trials

Immunome Reports Strong Q3 2026 Financial Results and Advances Oncology Pipeline with New Clinical Trials

Immunome Reports Strong Q3 2026 Financial Results and Advances Oncology Pipeline with New Clinical Trials
ReutersReuters
Corteva shares plunge as CEO warns Brazil slump will drag on

Corteva shares plunge as CEO warns Brazil slump will drag on

By Vallari Srivastava and Khusbu Jena Nov 12 (Reuters) - Corteva shares sank to a more than one-year low on Thursday and were on track for their steepest single-day percentage drop ever, as the US agrichemicals firm warned of continued weakness in the Brazilian market for the rest of the year.
TrendlineTrendline
CITGO Petroleum Corporation Reports Record Third-Quarter 2026 Financial Results

CITGO Petroleum Corporation Reports Record Third-Quarter 2026 Financial Results

CITGO Petroleum Corporation Reports Record Third-Quarter 2026 Financial Results
TrendlineTrendline
Via Transportation Reports Strong Q3 Earnings, Projects First Profitable Quarter

Via Transportation Reports Strong Q3 Earnings, Projects First Profitable Quarter

Via Transportation Reports Strong Q3 Earnings, Projects First Profitable Quarter